Skip to main content

Table 1 Characteristics of children receiving intranasal dexmedetomidine combined with oral midazolam sedation for MRI examination

From: Combined sedation in pediatric magnetic resonance imaging: determination of median effective dose of intranasal dexmedetomidine combined with oral midazolam

 

Group D(n = 26)

Group M(n = 27)

P-value

Male/Female(n/n)

12/14

17/10

0.219

Age (month)

18 [6, 36]

37[8, 49]

0.109

Weight (kg)

12.06 ± 4.84

14.19 ± 5.69

0.149

ASA (I/II)

21/5

25/2

0.250

Successful sedation(n)

14

14

 

 Examination time (min)

7.0[7.0, 10.0]

7.0[6.8, 8.0]

0.217

 Sedation onset time (min)

30.0[25.0, 38.0]

19.5[15.0, 35.0]

0.027

 Sedation recovery time (min)

81.2 ± 26.0

73.6 ± 28.3

0.463

 Overall sedation time (min)

112.4 ± 23.0

98.2 ± 30.0

0.171

  1. Notes Data are presented as the number of patients (n/n), median [IQR] or mean ± SD
  2. Abbreviations ASA, American Society of Anesthesiology; SD, standard deviation; IQR, interquartile range